Taiyen Biotech Co., Ltd.

TWSE:1737 Stock Report

Market Cap: NT$6.5b

Taiyen Biotech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Shi-Hui Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Jul 31
Taiyen Biotech's (TWSE:1737) Dividend Will Be Reduced To NT$1.20

Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

May 09
Investors Can Find Comfort In Taiyen Biotech's (TWSE:1737) Earnings Quality

Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Apr 24
Taiyen Biotech (TPE:1737) Has A Pretty Healthy Balance Sheet

Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

Apr 09
Taiyen Biotech's (TPE:1737) Returns On Capital Are Heading Higher

A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Mar 25
A Look At The Intrinsic Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Mar 12
Is Taiyen Biotech Co., Ltd. (TPE:1737) Popular Amongst Institutions?

Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 14
Taiyen Biotech Co., Ltd. (TPE:1737) Stock's On A Decline: Are Poor Fundamentals The Cause?

Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Feb 01
Taiyen Biotech Co., Ltd. (TPE:1737) Investors Should Think About This Before Buying It For Its Dividend

Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Jan 17
Taiyen Biotech (TPE:1737) Seems To Use Debt Quite Sensibly

Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

Jan 04
Returns On Capital - An Important Metric For Taiyen Biotech (TPE:1737)

A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

Dec 22
A Look At The Fair Value Of Taiyen Biotech Co., Ltd. (TPE:1737)

How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Dec 09
How Much Of Taiyen Biotech Co., Ltd. (TPE:1737) Do Institutions Own?

Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

Nov 24
Shareholders Of Taiyen Biotech (TPE:1737) Must Be Happy With Their 53% Return

CEO

Shi-Hui Chen

3.8yrs

Tenure

Mr. Shi-Hui Chen serves as President at Taiyen Biotech Co., Ltd. since 2021. He served as Vice President of Taiyen Biotech Co., Ltd.He served as Spokesperson of Taiyen Biotech Co., Ltd. He served as Direc...


Leadership Team

NamePositionTenureCompensationOwnership
Shi-Hui Chen
President3.8yrsno datano data
Wei Su
Director of Financial Accounting Departmentno datano datano data
An-Ping Ho
Director of Administrative Department & Representative Directorless than a yearno datano data
Tung-Hsuan Yang
Director of Legal Affairs Officeno datano datano data
Chieh-Han Lee
VP & Director of Corporate Development Departmentno datano data0.00089%
NT$ 57.8k
Mei-Wen Chen
Director of Branding & Marketing Departmentno datano datano data
Mei-Yu Chuang
Chief Internal Auditor2yrsno datano data

2.0yrs

Average Tenure

Experienced Management: 1737's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
An-Ping Ho
Director of Administrative Department & Representative Directorless than a yearno datano data
Yen-Che Ting
Chairman of the Boardless than a yearno datano data
Hsien-Kuei Liao
Directorno datano datano data
Kuan-Ping Chen
Director5.4yrsno datano data
Chien-Lung Chan
Independent Director5.4yrsno datano data
Shun-Tien Huang
Independent Director5.4yrsno datano data
Ying-Man Kuo
Independent Director5.4yrsno datano data
Shih-Hao Wu
Independent Director2.3yrsno datano data
Chia-Ling Lee
Independent Director2.3yrsno datano data
Yu-Pen Lin
Independent Director1.4yrsno datano data
Wei-I Chu
Representative Director1.3yrsno datano data

2.3yrs

Average Tenure

Experienced Board: 1737's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.